Invention Grant
- Patent Title: 4′-or nucleosides for the treatment of HCV
-
Application No.: US15104706Application Date: 2014-12-17
-
Publication No.: US10683321B2Publication Date: 2020-06-16
- Inventor: David Dukhan , Cyril B. Dousson , Adel M. Moussa , Benjamin Alexander Mayes , Alistair James Stewart
- Applicant: IDENIX PHARMACEUTICALS LLC
- Applicant Address: US MA Cambridge
- Assignee: Idenix Pharmaceuticals LLC
- Current Assignee: Idenix Pharmaceuticals LLC
- Current Assignee Address: US MA Cambridge
- Agent Jeffrey P. Bergman; Catherine D. Fitch
- International Application: PCT/US2014/070993 WO 20141217
- International Announcement: WO2015/095419 WO 20150625
- Main IPC: C07H19/207
- IPC: C07H19/207 ; C07H19/10 ; C07H19/16 ; C07H19/06 ; C07H19/20 ; A61P31/14

Abstract:
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are 4′-OR nucleosides of Formula I: or a pharmaceutically acceptable salt thereof, wherein Base, PD, R, Z1, Z2, Z3, and Z4 are as defined herein.
Public/Granted literature
- US20180162898A1 4'-OR NUCLEOSIDES FOR THE TREATMENT OF HCV Public/Granted day:2018-06-14
Information query
IPC分类: